Tuberculosis trials in South Africa
33 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRapid Research in Diagnostics Development for TB Network
- Where
- Cape Town
- Age
- 12 years and over
- People
- 26,436 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT04923958 - No phaseNot yet taking people in South AfricaPulmonary Rehabilitation in African Countries
- Where
- Johannesburg
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- University of Edinburgh
See details and how to joinNCT07602673 - Phase 2Taking peopleEvaluating the Safety and Immunogenicity of MTBVAC
- Where
- Cape Town, Chatsworth, Durban, Isipingo, Johannesburg, Klerksdorp, Ladysmith, Rustenburg, Soshanguve, Westdene, Worcester
- Age
- 12 years to 55 years
- People
- 276
- Run by
- HIV Vaccine Trials Network
See details and how to joinNCT05947890 - No phaseTaking peopleBring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
- Where
- East London, Pietermaritzburg, Port Elizabeth, Port Shepstone
- Age
- 18 years and over
- People
- 2,944
- Run by
- Johns Hopkins University
See details and how to joinNCT05671718 - Phase 3Taking peopleOptimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
- Where
- Johannesburg
- Age
- 16 years and over
- People
- 784 worldwide
- Run by
- University College, London
See details and how to joinNCT07163143 - Phase 3Taking peopleA Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
- Where
- Belville, Cape Town, Durban, East London, Johannesburg, Klerksdorp, Port Elizabeth, Pretoria, Rustenburg, Soweto
- Age
- 14 years and over
- People
- 532 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07209761 - No phaseTaking peopleRapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)
- Where
- Cape Town
- Age
- Up to 65 years
- People
- 2,100 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT05989802 - Phase 2Taking peoplePlatform Assessing Regimens and Durations In a Global Multisite Consortium for TB
- Where
- Cape Town, George
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- University College, London
See details and how to joinNCT06114628 - No phaseEnrolling by invitationSystems Analysis and Improvement Approach to Prevent TB
- Where
- Addo, Alexandria, Boesmansriviermond, Hankey, Humansdorp, Jeffrey's Bay, Joubertina, Kareedouw, Kenton on Sea, Kirkwood, Patensie, Port Alfred
- Age
- 0 years and over
- People
- 19,560
- Run by
- Boston College
See details and how to joinNCT06314386 - Phase 2Not yet taking people in South AfricaStudy of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis
- Where
- Cape Town
- Age
- 18 years to 65 years
- People
- 135
- Run by
- TASK Applied Science
See details and how to joinNCT07773610 - No phaseTaking peopleSouth Africa Smoking Cessation and Engagement in HIV/TB Care Care
- Where
- Rondebosch
- Age
- 18 years and over
- People
- 83
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05842161 - Phase 2Taking peopleEffects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial
- Where
- Klerksdorp
- Age
- 18 years to 45 years
- People
- 40
- Run by
- North-West University, South Africa
See details and how to joinNCT07118059 - Phase 2Taking peopleSorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB
- Where
- Brits, Cape Town, East London, Klerksdorp, Port Elizabeth, Rustenburg, Soshanguve, Wentworth
- Age
- 18 years to 65 years
- People
- 100 worldwide
- Run by
- Global Alliance for TB Drug Development
See details and how to joinNCT07672405 - Phase 2Taking peopleBactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
- Where
- Bethelsdorp, Brits, Cape Town, Durban, East London, George, Johannesburg, Pretoria, Tembisa
- Age
- 18 years to 65 years
- People
- 150
- Run by
- Gates Medical Research Institute
See details and how to joinNCT07525427 - Phase 3Taking peopleShortened Regimen for Drug-susceptible TB in Children
- Where
- Durban
- Age
- 0 days to 9 years
- People
- 860 worldwide
- Run by
- Johns Hopkins University
See details and how to joinNCT06253715 - No phaseTaking peopleTesting Health Workers At Risk to Advance Our Understanding of TB Infection
- Where
- Cape Town
- Age
- 18 years to 100 years
- People
- 300
- Run by
- Beth Israel Deaconess Medical Center
See details and how to joinNCT06221488 - Phase 3Not yet taking people in South AfricaA 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis
- Where
- Cape Town, Klerksdorp
- Age
- 15 years and over
- People
- 294
- Run by
- Seoul National University Hospital
See details and how to joinNCT07675954 - Phase 3Taking peopleIntensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
- Where
- Cape Town, Port Elizabeth
- Age
- 15 years and over
- People
- 768 worldwide
- Run by
- ANRS, Emerging Infectious Diseases
See details and how to joinNCT04145258 - Phase 2Taking peopleTrial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
- Where
- Durban, Johannesburg
- Age
- 15 years and over
- People
- 330 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05383742 - No phaseTaking peopleAn Adaptive Randomized Controlled Trial
- Where
- Durban
- Age
- 18 years and over
- People
- 360
- Run by
- Columbia University
See details and how to joinNCT05633056 - Phase 2/3Taking peopleAssessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- Where
- Stellenbosch
- People
- 3,400 worldwide
- Run by
- Centers for Disease Control and Prevention
See details and how to joinNCT03474029 - No phaseTaking peoplePre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
- Where
- Cape Town
- Age
- 18 years to 60 years
- People
- 150
- Run by
- University of Stellenbosch
See details and how to joinNCT04700579 - No phaseNot yet taking people in South AfricaTest to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
- Where
- Cape Town
- Age
- 18 years and over
- People
- 280
- Run by
- University of Cape Town
See details and how to joinNCT05007795 - No phaseTaking peopleCough Audio Classification as a TB Triage Test
- Where
- Cape Town
- Age
- 12 years and over
- People
- 1,751 worldwide
- Run by
- University of Stellenbosch
See details and how to joinNCT05317247 - No phaseTaking peopleTherapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
- Where
- East London
- Age
- 18 years and over
- People
- 280
- Run by
- Albert Einstein College of Medicine
See details and how to joinNCT06590428